NewsBenzingaOncolytics Biotech宣布一项正在进行的研究的新转化数据:Pelareorep可增加二线及以上鳞状细胞肛癌患者中HPV-16特异性T细胞克隆和肿瘤浸润淋巴细胞克隆;几乎所有患者在一个治疗周期后免疫激活水平翻倍以上;当Pelareorep与免疫检查点抑制剂联用时,观察到HPV-16特异性T细胞和肿瘤浸润淋巴细胞显著增加 Oncolytics Biotech宣布一项正在进行的研究的新转化数据:Pelareorep可增加二线及以上鳞状细胞肛癌患者中HPV-16特异性T细胞克隆和肿瘤浸润淋巴细胞克隆;几乎所有患者在一个治疗周期后免疫激活水平翻倍以上;当Pelareorep与免疫检查点抑制剂联用时,观察到HPV-16特异性T细胞和肿瘤浸润淋巴细胞显著增加 Benzinga 2026.11.04 14:33 (GMT+0) Open on Benzinga Other news Billionaires Walk Away From Alphabet in Q3 - Hedge Funds Google ‘How to Sell’ and Hit Enter $100 Invested In Visa 15 Years Ago Would Be Worth This Much Today Western Digital Gains, Seagate Flat As Nvidia’s Raised Outlook Lifts AI Storage Hopes Home Depot Posts Strongest Comps In 4 Years, Analysts Revise Price Targets TJ Maxx Parent Bets on Accelerating Sales This Holiday Season Why Is Coinbase Stock Falling on Wednesday?